Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | AKT1 | P31749 | 2/20 | 0.40 |
| ▸ | AKT2 | P31751 | 1/20 | 0.40 |
| ▸ | PDE2A | O00408 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3638924 | 0.81 | TP53 (0.45) | PDE10ATP53AKT1AKT2PDE2A | |
| SCHEMBL1163063 | 0.78 | MAPT (0.50) | PDE10ATP53AKT1AKT2KDM4E | |
| SCHEMBL25781181 | 0.77 | PDE10A (0.42) | PDE10ANPSR1TP53AKT1AKT2 | |
| SCHEMBL19054144 | 0.77 | KDM4E (0.47) | PDE10ANPSR1TP53AKT1AKT2 | |
| SCHEMBL13052928 | 0.77 | TP53 (0.51) | PDE10ANPSR1TP53AKT1AKT2 | |
| SCHEMBL3641378 | 0.77 | TP53 (0.45) | PDE10ANPSR1TP53AKT1AKT2 | |
| SCHEMBL18347135 | 0.77 | PDE10A (0.42) | PDE10ANPSR1TP53AKT1AKT2 | |
| Ammonia Solution, Strong SCHEMBL17962224 | 0.77 | MAPT (0.49) | PDE10ATP53AKT1AKT2KDM4E | |
| SCHEMBL13052922 | 0.74 | PDE10A (0.56) | PDE10ATP53AKT1AKT2MAPT | |
| SCHEMBL1106498 | 0.74 | CSNK1E (0.47) | PDE10ANPSR1TP53AKT1AKT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11818932-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-11696491-B2 | Organometallic compound, organic light-emitting device including the same and apparatus including the organometallic compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11696499-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11678498-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| US-11617290-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-03-28 | — | — | US | disclosed |
| US-20220190296-A1 | LIGHT-EMITTING DEVICE AND AN ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-06-16 | — | — | US | disclosed |
| US-11329230-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-10 | — | — | US | disclosed |
| US-11316117-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-04-26 | — | — | US | disclosed |
| US-11158815-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-10-26 | — | — | US | disclosed |
| US-20170317294-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-02 | — | — | US | disclosed |
| US-20170294489-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-10-12 | — | — | US | disclosed |
| US-20170294587-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-10-12 | — | — | US | disclosed |
| US-20170294613-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-10-12 | — | — | US | disclosed |
| US-20170179401-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170179402-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170179204-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170179397-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170179396-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170179416-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11158815-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNE2 | PDE10A 2472/4885NPSR1 4281/4885TP53 3157/4885 |
| US-11329230-B2 | Organic light-emitting device | EML4, SUN2, TRPA1 | PDE10A 3747/4885NPSR1 4569/4885TP53 4691/4885 |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | C1S, CCNT1, C9 | PDE10A 2420/4885NPSR1 3613/4885TP53 4307/4885 |
| US-11316117-B2 | Organometallic compound and organic light-emitting device including the same | OCIAD1, L3MBTL1, OCIAD2 | PDE10A 4805/4885NPSR1 3369/4885TP53 1869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.